David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSRA
326
DELISTED
CSRA Inc.
CSRA
| $47.7M | 0.07% |
1,478,054
+54,152
| +4% | +$1.75M |
|
327
PUT
Tesla
TSLA
$1.43T
| $47.7M | 0.07% |
2,097,000
+1,497,000
| +250% | +$34.5M |
|
328
PTC Therapeutics
PTCT
$5.83B
| $47.3M | 0.07% |
2,362,968
-358,707
| -13% | -$7.02M |
|
|
LL
329
DELISTED
LL Flooring Holdings, Inc.
LL
| $47.1M | 0.07% |
1,209,324
+1,184,157
| +4,705% | +$39.4M |
|
330
Bruker
BRKR
$9.07B
| $47M | 0.07% |
1,578,615
+160,797
| +11% | +$4.63M |
|
331
Reliance Steel & Aluminium
RS
$19.8B
| $46.8M | 0.07% |
613,924
+61,916
| +11% | +$4.52M |
|
|
APC
332
PUT
DELISTED
Anadarko Petroleum
APC
| $46.7M | 0.07% |
956,100
+311,500
| +48% | +$13.7M |
|
333
CALL
Apple
AAPL
$4.51T
| $46.7M | 0.07% |
1,211,600
-1,262,000
| -51% | -$49M |
|
|
CMA
334
DELISTED
Comerica
CMA
| $46.1M | 0.07% |
604,715
+27,976
| +5% | +$2M |
|
335
CALL
Regeneron Pharmaceuticals
REGN
$85.9B
| $46M | 0.07% |
102,900
+4,000
| +4% | +$1.9M |
|
|
MDRX
336
DELISTED
Veradigm Inc. Common Stock
MDRX
| $45.9M | 0.07% |
3,223,291
+1,411,268
| +78% | +$18.3M |
|
|
FDC
337
DELISTED
First Data Corporation
FDC
| $45.6M | 0.07% |
2,525,071
+350,878
| +16% | +$6.4M |
|
338
CALL
McDonald's
MCD
$192B
| $45.4M | 0.07% |
289,700
-1,500
| -0.5% | -$235K |
|
339
CALL
FedEx
FDX
$76.9B
| $45.1M | 0.07% |
200,000
+21,300
| +12% | +$4.53M |
|
340
MSCI
MSCI
$41B
| $45M | 0.07% |
384,676
+20,430
| +6% | +$2.27M |
|
|
MXIM
341
DELISTED
Maxim Integrated Products
MXIM
| $45M | 0.07% |
942,265
+120,018
| +15% | +$5.5M |
|
|
342
PUT
FedEx
FDX
$76.9B
| $44.9M | 0.07% |
199,000
+37,600
| +23% | +$8.01M |
|
343
Delta Air Lines
DAL
$54.2B
| $44.5M | 0.07% |
922,363
-3,090,420
| -77% | -$154M |
|
344
Keurig Dr Pepper
KDP
$43.6B
| $44.2M | 0.07% |
499,060
+184,649
| +59% | +$16.8M |
|
|
MIK
345
DELISTED
Michaels Stores, Inc
MIK
| $44M | 0.07% |
2,051,526
+712,704
| +53% | +$14.5M |
|
|
MRSH
346
Marsh
MRSH
$91.6B
| $43.3M | 0.07% |
516,224
-296,401
| -36% | -$23.5M |
|
347
AT&T
T
$173B
| $43.2M | 0.07% |
1,459,210
-6,795,767
| -82% | -$193M |
|
|
DGI
348
DELISTED
DigitalGlobe Inc.
DGI
| $43M | 0.07% |
1,220,959
-8,084
| -0.7% | -$276K |
|
|
JUNO
349
DELISTED
Juno Therapeutics, Inc.
JUNO
| $42.9M | 0.07% |
956,524
+915,730
| +2,245% | +$31.2M |
|
350
US Foods
USFD
$23.7B
| $42.7M | 0.07% |
1,600,279
+758,317
| +90% | +$20.8M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.